Screener
Johnson & Johnson JNJ General Corporate — Litigation expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Johnson & Johnson in its filing.
Tagged under the XBRL concept us-gaap:LitigationSettlementExpense.
The source filing: Johnson & Johnson’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000200406-26-000153
(4) Amounts not allocated to segments include interest (income)/expense and general corporate (income)/expense. The fiscal second quarter and fiscal six months of 2026 include charges for talc matters of $0.4 billion and $0.8 billion, respectively. The fiscal six months of 2025 includes approximately $7.0 billion related to the talc reserve reversal.
Item 1 — Financial statements
FAQ
- What is Johnson & Johnson's general corporate — litigation expense?
- Johnson & Johnson (JNJ) reported general corporate — litigation expense of $400M in Q2 2026.
- What does general corporate — litigation expense mean?
- This metric tracks the costs associated with legal proceedings, settlements, and provisions for potential losses within the general corporate segment. It captures the financial impact of legal risks that are not directly attributable to specific operating business units. Monitoring this helps investors assess the company's exposure to legal liabilities and the potential volatility of corporate earnings.
Ask your AI about Johnson & Johnson's general corporate — litigation expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude